It’s good to hear that there will be a review of private prescribing of cross sex hormones for under 18s, but what is long overdue is a review of prescribing to under 18s within the NHS. It is scandalous that the current NHS policy to prescribe these has not been updated since the Cass Review finding of no good quality evidence of benefit, as well as increasing concerns about irreversible and harmful long term effects.
